Performance Study of Targeted Sequencing Technology for VAP

Not yet recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

October 30, 2025

Conditions
VAP - Ventilator Associated Pneumonia
Interventions
DEVICE

tNGS

By means of super-multiple PCR amplification or probe hybridization capture, tNGS can enrich dozens to hundreds of known pathogenic microorganisms and their virulence and drug resistance genes in the samples to be tested, and then conduct high-throughput sequencing.

All Listed Sponsors
lead

The First Hospital of Jilin University

OTHER

NCT06035796 - Performance Study of Targeted Sequencing Technology for VAP | Biotech Hunter | Biotech Hunter